Latest Articles

Consensus Guidance for Monitoring Children with Islet Autoantibody-Positive Pre-Stage 3 Autoimmune Type 1 Diabetes (T1D)

Considerations for bullous pemphigoid management

The management of bullous pemphigoid is challenging and new treatment approaches are needed. Read this article to find out more.

What is Bullous Pemphigoid

The heterogeneous presentation of bullous pemphigoid may shed light on why patients are underdiagnosed. Read the article to learn more

Treatments and challenges for bullous pemphigoid

Systemic corticosteroids and other immunosuppressants are the current mainstay of therapy but carry risks for patients with bullous pemphigoid. Read this article to find out more

Future of ITP

Pathophysiology of Bullous Pemphigoid

In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more

What is ITP?

Patient morbidity and mortality in BP

Many factors, including older age and multimorbidity, are associated with mortality in bullous pemphigoid. Read this article to find out more

Understanding ITP